How to Price a Skincare Product: A Formulator’s View
“I don’t think pricing begins with asking what markup you want. It begins with understanding what the product needs to cost if the business is going to work.”
One of the easiest mistakes a new beauty brand can make is deciding what a skincare product should cost after the formula is developed.
A founder creates the concept, chooses premium actives, falls in love with expensive packaging, gets a manufacturing quote, and then tries to figure out whether the product should retail for $38, $48, or $68.
By then, many of the decisions controlling profitability have already been made.
Pricing should work in both directions.
The market tells you roughly what consumers are willing to pay for the type of product you're creating. Your desired sales channels tell you how much margin needs to exist inside that retail price. Then formulation, packaging, fill size, manufacturing, and ingredient choices need to be developed within those economics.
That doesn't mean creating the cheapest formula possible.
It means developing a product whose performance, positioning, cost, and retail price make sense together.
How Do You Price a Skincare Product?
At the simplest level, a skincare brand needs to know four things:
What does one finished unit actually cost?
What gross margin does the business need?
Which sales channels will the product eventually need to support?
What price will the target consumer accept for this particular product and brand?
Those questions should be answered together.
A $10 cost of goods may be completely reasonable for one $100 prestige treatment and unsustainable for another product intended to retail at $28 through wholesale.
Likewise, getting COGS down to $3 doesn't automatically mean the right retail price is $15.
Pricing is not simply:
cost × markup = retail
It is a combination of unit economics, market positioning, channel strategy, perceived value, and product strategy.
Start With COGS, but Understand What COGS Actually Means
Cost of Goods Sold, or COGS, is the direct cost required to produce the finished unit you sell.
For a cosmetic product, that can include the bulk formula, primary packaging, filling, manufacturing labor, labels, cartons, direct assembly, and other costs directly associated with creating the finished product. Cosmeta's deeper guide to COGS in Cosmetic Manufacturing explains these components in detail.
COGS generally does not mean every expense associated with running the company.
It does not normally include broader operating expenses such as:
Marketing
Salaries not directly tied to production
Office expenses
Website costs
Public relations
General administrative costs
That distinction matters because founders sometimes calculate what looks like an excellent gross margin and then wonder where the money went.
Gross margin has to pay for the rest of the business.
The Formula Is Only One Part of Product Cost
Founders often focus heavily on ingredient cost because formulation feels like the obvious source of COGS.
Sometimes it is.
Often packaging matters just as much, or more.
A skincare product may include direct costs for:
Bulk formulation
Bottle, jar, or tube
Pump or dropper
Cap or closure
Label
Carton
Filling
Assembly
Manufacturing
Quality procedures
Direct inbound freight or duties, depending on how the company defines landed COGS
A $3 formula in a $4 packaging system is no longer a $3 product.
And once premium pumps, decorated bottles, custom molds, component assembly, or specialty cartons enter the picture, packaging can become a major part of the economics.
This is why Cosmeta treats packaging as part of product development rather than simply a branding decision made at the end.
Formula Cost Still Matters More Than Founders Sometimes Realize
The opposite mistake happens too.
A founder sees that most of a moisturizer is water and assumes ingredient cost is insignificant.
That can change quickly.
A formula may contain:
Patented peptides
Ceramides
Biotechnology-derived actives
Specialty botanical extracts
Encapsulated ingredients
High-cost antioxidants
Premium emollients
Natural fragrance technologies
High levels of expensive hero ingredients
The concentration matters.
So does the commercial raw material.
A peptide appearing at a low level on the INCI list may be supplied through an expensive proprietary complex. A ceramide system may cost substantially more than its apparent use level suggests. A biotech active may carry a high price per kilogram even though only a modest percentage is used.
This is where quantitative formulation becomes a business tool.
A cosmetic chemist isn't only asking:
Will this ingredient work?
The chemist should also be asking:
Does the value it adds justify what it does to COGS?
Formulation Should Have a Target COGS
One of the most useful things a founder can give a formulator is a target economic range.
Not necessarily:
“The formula has to cost exactly $2.14.”
But something like:
“We expect this to retail around $48, we want to preserve the option to enter wholesale later, and packaging is likely to cost around $3.”
Now formulation decisions have commercial context.
If an additional active adds $0.80 to every unit, we can ask whether that ingredient improves the product enough to justify the increase.
If the formula is already approaching the target cost before packaging, we can adjust early.
That is much easier than developing an expensive formula first and trying to remove the things that made everyone approve it.
Why Pricing Should Be Considered During Formulation
Formulation decisions can quietly lock in the future economics of the product.
An expensive ingredient may affect more than raw-material cost.
It may also require:
A high supplier minimum
Longer lead times
Specialty storage
Additional processing
Different packaging
More analytical testing
Additional manufacturing complexity
Likewise, a difficult formula may take longer to manufacture or require equipment not every contract manufacturer has.
That can affect both direct cost and manufacturing flexibility.
Pricing therefore begins earlier than the manufacturing quote.
It begins while the product architecture is still being decided.
The Basic Gross Margin Formula
Gross margin is one of the most useful calculations for a beauty founder.
The basic formula is:
Gross Margin % = (Selling Price − COGS) ÷ Selling Price × 100
If a product retails directly to the consumer for $50 and has $10 COGS:
Gross profit is $40.
Gross margin is:
($50 − $10) ÷ $50 = 80%
That sounds excellent.
But it does not mean the brand makes $40 of profit every time it sells the product.
It means $40 remains before many other business costs are paid.
That distinction is critical.
Gross Margin Is Not Net Profit
Gross margin is what remains after COGS.
Net profit is what remains after the rest of the business has been paid for.
Those additional expenses may include:
Customer acquisition
Agency fees
Influencers
Affiliate commissions
Warehousing
Pick-and-pack
Outbound shipping subsidies
Returns
Discounts
Samples
Payment-processing fees
Employees
Insurance
Software
Legal and regulatory expenses
Product development
Overhead
Beauty can appear to be an extraordinarily high-margin category when viewed only through gross margin.
Operating a beauty brand is considerably less simple.
Recent beauty-industry analysis has emphasized the importance of contribution margin, because a strong gross margin can shrink dramatically after customer acquisition, fulfillment, returns, and other variable selling costs are included.
Markup and Margin Are Not the Same Thing
These terms are frequently confused.
If a product costs $10 and sells for $50, the markup on cost is:
($50 − $10) ÷ $10 = 400%
But the gross margin is:
($50 − $10) ÷ $50 = 80%
Same product.
Two very different percentages.
For pricing a beauty brand, I generally find gross margin more useful because it tells you how much of sales revenue remains after product cost.
A founder saying:
“We have a 5X markup.”
still hasn't told me whether the business works.
I want to know the channel and the margin.
Why the Famous “10X COGS” Rule Exists
Beauty founders will often hear that retail price should be roughly 8X, 10X, or even more than product COGS.
There is some logic behind the rule of thumb.
Beauty Independent has described a roughly 10-to-1 relationship between COGS and retail price as common beauty-industry economics, largely because the retail price has to support retailer margin as well as the brand's operating expenses and profit.
But I would not use 10X COGS as a law.
A brand selling almost entirely DTC has different economics from a brand built around Sephora, Ulta, spas, professional distribution, distributors, or international wholesale.
A $5 COGS product doesn't automatically need to cost $50.
And a $50 retail product doesn't automatically need to have a $5 COGS.
The multiplication rule is useful as an early sanity check.
The channel math is more important.
Why Sales Channel Changes Everything
Imagine a product with a $50 suggested retail price.
If the brand sells it directly on its own website for $50, it receives the retail revenue before payment fees, fulfillment, shipping, discounts, customer acquisition, returns, and other selling costs.
If the product is sold through a retailer, the brand does not usually receive $50.
A traditional wholesale structure may give the retailer a substantial portion of the retail price. Beauty industry pricing discussions frequently use approximately 50% of retail as a simple wholesale starting assumption, although actual terms vary by retailer and agreement.
So the same $50 product may create approximately:
DTC revenue to brand: $50
versus roughly:
Wholesale revenue to brand: $25
before considering other terms.
Now imagine the product has $10 COGS.
At $50 DTC revenue, the product has $40 of gross profit before selling expenses.
At $25 wholesale revenue, it has $15.
Same formula.
Same package.
Same shelf price.
Completely different economics.
Price for the Channel You Want Tomorrow
This is one of the most important pieces of pricing advice I would give an early beauty brand.
Do not price only for the channel you have today if you realistically want different channels later.
A founder launches DTC and says:
“We can afford to sell this serum for $28 because it only costs us $7.”
Maybe.
But if the brand later wants to sell through a retailer that purchases around half of suggested retail, the brand might receive about $14.
Now subtract $7 COGS.
Only $7 remains before the brand's wholesale-side operating costs.
That can become uncomfortable quickly.
A product that looked profitable on Shopify can become commercially difficult when wholesale appears.
Recent beauty finance analysis similarly shows why DTC and retail need to be modeled differently: DTC can produce a higher gross margin before customer-acquisition and fulfillment costs, while wholesale begins with a lower brand-side gross margin because the retailer participates in the economics.
The best time to discover that is before launch, not when a major retailer becomes interested.
DTC Does Not Mean You Get to Keep the Entire Margin
Direct-to-consumer brands often look incredible in a simple spreadsheet.
Retail price: $50.
COGS: $10.
Gross margin: 80%.
Wonderful.
Then reality arrives.
The product may need:
Paid advertising
Affiliate commission
15% promotional discount
Free shipping
Pick-and-pack
Payment processing
Customer service
Returns
That is why gross margin and contribution margin need to be considered separately.
One current beauty-industry finance analysis estimates DTC beauty gross margins commonly in the mid-60s to low-70s before customer acquisition and other selling costs, but actual economics vary significantly by brand, product mix, and how costs are classified.
The exact benchmark matters less than the principle:
A beautiful gross margin does not guarantee a profitable customer order.
Wholesale Is Not Automatically Worse Than DTC
It is tempting to see the retailer's margin and conclude that DTC is always financially superior.
That is also too simple.
Retail can provide:
Customer discovery
Physical distribution
Credibility
Retail traffic
Merchandising
Reduced direct customer-acquisition burden
Larger order quantities
DTC may preserve more gross margin but require the brand to pay directly to acquire and fulfill the customer.
Wholesale gives up part of the selling price in exchange for part of the distribution function.
The correct question isn't:
Which channel has the highest gross margin?
It is:
Which channel produces sustainable contribution margin and growth for this particular brand?
Amazon Needs Its Own Math Too
Amazon should not simply be modeled as either DTC or traditional wholesale.
Depending on the selling structure, brands may face referral fees, fulfillment costs, storage, advertising, returns, promotions, and other marketplace expenses.
The consumer may still see the same $48 retail price they see on the brand website.
The economics underneath can be very different.
That is why serious pricing models should evaluate every likely channel independently.
One MSRP can produce several different margins.
MSRP Should Leave Room for the Business to Grow
A strong suggested retail price should ideally support more than one perfect-case transaction.
It may eventually need room for:
Retailer margin
Distributor margin
Promotional events
Affiliate commission
Sampling
Returns
Damages
International distribution
Currency fluctuations
Freight increases
Raw-material inflation
Packaging increases
This does not mean founders should artificially inflate prices.
It means pricing too close to the minimum viable margin can create a fragile business.
You need some room for reality.
Discounts Have to Be Designed Into the Price Too
A product that only works financially when sold at full MSRP is probably priced too tightly.
Beauty consumers are trained to expect promotions.
Brands run:
Launch offers
Holiday sales
Bundles
Subscribe-and-save
Influencer codes
Affiliate discounts
Retailer events
Loyalty rewards
Gift-with-purchase programs
A 20% discount on a $50 product means the brand is now selling it for $40.
The $10 COGS did not change.
At full price, the product had an 80% gross margin.
At $40, gross margin falls to 75%.
Still healthy in that example.
But now add an affiliate commission, payment fees, fulfillment, shipping support, and customer acquisition.
The economics can tighten quickly.
This is why I would rather build room for promotions into the original pricing architecture than discover later that every successful marketing event damages contribution margin.
Retail Promotions Can Hit Twice
Retail creates another layer because the brand may already be selling the product to the retailer at a wholesale price.
Then the retailer runs a promotion.
Who funds the discount depends on the agreement.
A brand may participate in:
Promotional allowances
Markdown support
Cooperative marketing
Sampling
Tester units
Free goods
Retailer-specific programs
So the original wholesale margin isn't necessarily the final economics of that account.
The practical lesson is simple:
Do not model retail assuming every unit sells at full wholesale price with no additional costs.
Terms vary enormously by retailer, and they should be understood before the brand commits to the channel.
Distributor Economics Require Another Layer of Margin
International expansion and professional distribution can introduce another participant between the brand and retailer.
The chain may become:
Brand → Distributor → Retailer → Consumer
Each participant needs enough economic incentive to carry the product.
That means a retail price that works for DTC and direct wholesale may become difficult if the brand later adds distribution without having planned for it.
This does not mean every startup needs to price as though it will become a global prestige brand.
It means founders should know which future channels are plausible.
If international distribution is part of the long-term plan, that belongs in the pricing conversation early.
Contribution Margin Is Where the Business Starts Becoming Real
Gross margin tells us what remains after COGS.
Contribution margin goes a step further and subtracts the variable costs associated with actually making the sale.
Depending on the business, that may include costs such as:
Payment processing
Pick-and-pack
Outbound fulfillment
Shipping subsidies
Affiliate commission
Marketplace fees
Returns
Variable advertising or customer acquisition
Beauty finance discussions increasingly focus on contribution margin for exactly this reason: a brand can have a strong product gross margin and still lose money acquiring and fulfilling individual orders.
For a founder, I would think of the progression this way:
Retail price tells you what the consumer pays.
Gross margin tells you whether the product economics work.
Contribution margin tells you whether the transaction economics work.
Net profit tells you whether the business works.
Those are four different questions.
CAC Can Completely Change the Meaning of a High-Margin Product
Customer Acquisition Cost, or CAC, is what a brand spends to acquire a new customer.
This is one of the reasons a product with an apparently enormous gross margin can still create a difficult DTC business.
Imagine:
Retail price: $50
COGS: $10
Gross profit before selling costs: $40
Now imagine it costs $30 in advertising to acquire the customer.
We have not yet accounted for:
Fulfillment
Payment processing
Shipping support
Returns
Customer service
Overhead
That first order may produce very little profit.
Or none.
The brand may still have an excellent business if customers reorder frequently, purchase several products, or eventually acquire through less expensive channels.
But now pricing connects directly to LTV, or customer lifetime value.
This is why skincare pricing cannot be evaluated only at the individual SKU level.
A $30 CAC Is Very Different for a $28 Product and a $120 Routine
Product architecture matters here.
If a brand spends $30 to acquire a customer who purchases one $28 moisturizer, the economics are difficult.
If that same acquisition brings in a customer purchasing:
$48 serum
$42 moisturizer
$28 cleanser
the economics look completely different.
That makes Average Order Value, or AOV, another part of pricing strategy.
Brands can improve economics without simply raising individual product prices by designing a portfolio that encourages logical multi-product purchasing.
This should still be driven by the consumer's actual routine.
Creating unnecessary SKUs solely to manufacture a larger cart is not a strong product strategy.
Product Price and Brand Economics Are Connected Through LTV
A skincare business has one advantage that many product categories do not:
Good products can be replenishable.
A consumer may repurchase a moisturizer, cleanser, serum, sunscreen, body product, or treatment several times a year.
That means the economics of the first purchase may not represent the full value of the customer relationship.
If the customer purchases repeatedly, their Lifetime Value can be substantially higher than the revenue from the first order.
This is why retention matters so much in beauty.
And retention brings us right back to formulation.
A product that produces strong first-order marketing but weak repurchase is very different from one consumers repeatedly empty and reorder.
The formula affects the financial model.
Repurchase May Be More Valuable Than Another Dollar of Margin
This is one of the places where I think formulation and finance become much more connected than founders initially realize.
Imagine reducing product COGS by $0.50.
Great.
But what if the change also makes the moisturizer noticeably less elegant?
If repurchase declines because consumers no longer love using it, the savings may have been expensive.
The reverse can happen too.
Adding another $2 of actives to a formula does not automatically create enough additional consumer value to justify the cost.
The formulator and brand need to ask:
Will the consumer notice this?
Does it improve performance?
Does it strengthen the product story?
Will it help drive repurchase?
Is that worth what it does to COGS?
That is formulation economics.
Don't Cost-Engineer Away the Reason Someone Loves the Product
COGS optimization is important.
But there is a difference between cost optimization and making the product cheaper.
Good cost optimization may involve:
Selecting a more efficient supplier
Increasing production scale
Reducing unnecessary packaging complexity
Removing redundant actives
Improving purchasing terms
Choosing a technically equivalent raw-material option where appropriate
Simplifying secondary packaging
Improving production efficiency
Bad cost optimization can mean removing the sensory or performance elements that made the product competitive.
A $1 reduction in COGS is not a win if the product becomes something consumers no longer want.
More Expensive Ingredients Don't Automatically Justify a Higher Retail Price
This is another misconception I see in product development.
An ingredient may be expensive.
That does not mean consumers will pay more for it.
Retail price is influenced by perceived value, which can include:
Brand positioning
Product performance
Consumer problem solved
Ingredient recognition
Clinical support
Packaging
Sensory experience
Competitive set
Distribution
Brand credibility
A technically fascinating $800-per-kilogram active may mean absolutely nothing to the consumer if nobody understands what it does.
Conversely, an inexpensive but familiar ingredient can have enormous marketing value.
That does not mean formulation should chase only familiar ingredients.
It means raw-material cost and consumer value are different measurements.
The strongest products align them where possible.
A High Percentage Claim Can Be an Expensive Marketing Decision
Ingredient percentages have become increasingly prominent in skincare.
10% niacinamide.
15% vitamin C.
2% something else.
Sometimes those concentrations are scientifically justified.
Sometimes they are commercially useful.
Sometimes the number mainly exists because consumers can compare it easily.
But percentage escalation can have real economic consequences.
Increasing an active can:
Raise raw-material cost
Increase irritation potential
Affect stability
Change viscosity
Increase tack
Create color or odor
Complicate manufacturing
Require different packaging
If 5% creates the desired performance and evidence story, taking the formula to 10% solely because another brand has 10% may produce a more expensive formula without producing a better product.
This is another reason pricing starts at the formulation bench.
Ingredient Stacking Has a Financial Cost Too
It is easy to create a $70 serum concept on paper.
Peptides.
Ceramides.
Vitamin C.
Niacinamide.
Ectoin.
N-Acetyl Glucosamine.
Three forms of hyaluronic acid.
Botanical extracts.
Now every ingredient sounds individually impressive.
But every additional raw material may add:
Cost
Supplier minimums
Freight
Lead time
Inventory
Quality documentation
Manufacturing complexity
The active list may also become so broad that the consumer no longer understands what the product is supposed to do.
There are times when multiple actives create a genuinely superior system.
There are also times when the commercially smarter formula has one strong hero technology and a small number of carefully selected supporting ingredients.
An ingredient has to earn its cost just as much as it has to earn its place in the formula.
MOQ Can Distort Early Product Economics
A manufacturing quote needs context.
Suppose a contract manufacturer quotes:
$8.50 per unit at 1,000 units.
$6.75 at 5,000 units.
$5.90 at 10,000 units.
The largest run produces the lowest unit COGS.
That does not automatically make 10,000 units the best business decision.
The brand now needs enough cash to purchase the inventory and enough demand to sell it before tying up capital becomes a larger problem than the unit-cost savings.
This is particularly important for new brands because inventory risk is real cost, even if it doesn't appear in the COGS formula the same way.
Lower unit cost is useful.
Unsold inventory is not.
The Cheapest Manufacturer Is Not Automatically the Lowest-Cost Manufacturer
Two manufacturers can quote the same formula very differently.
One may appear cheaper per unit but require:
Larger MOQ
More expensive packaging sourcing
Higher freight
Additional testing
Longer lead times
More manual assembly
Greater deposits
Less favorable payment terms
Another may have a slightly higher unit price but better operational fit.
Manufacturing economics should therefore be evaluated as a commercial system rather than a single number on a quote.
This becomes especially important as the business grows.
Scale Can Lower COGS, but Don't Build a Launch Model Around Future Scale
Yes, larger purchasing volumes can improve economics.
Raw materials may become less expensive per kilogram.
Packaging pricing may improve.
Manufacturing efficiencies may improve.
Freight may become more efficient.
But the product still needs to work at the volume the brand can realistically buy now.
I would be cautious about a business model that only becomes profitable once the brand reaches a production volume it has never demonstrated demand for.
Future scale should improve the economics.
It shouldn't be required to rescue them.
Fill Size Is a Pricing Decision
A founder may assume a 50 mL moisturizer is the standard.
But fill size affects:
Formula COGS
Package dimensions
Freight
Perceived value
Usage duration
Repurchase timing
Competitive positioning
A 30 mL concentrated serum and a 50 mL serum may look similar in formulation but create very different retail economics.
This does not mean shrinking the package simply to improve margin.
The amount should make sense for normal use.
But fill size belongs in the pricing model early.
Sometimes the most elegant way to hit a target price is not reducing the quality of the formula.
It is choosing the correct product size.
Packaging Can Quietly Destroy an Otherwise Good Price Architecture
Packaging deserves special attention because it can be surprisingly emotional.
Founders fall in love with components.
A beautiful custom bottle may feel essential to the brand.
And sometimes it is.
But the package has to earn its cost too.
Imagine two options:
One package costs $2.25.
The other costs $5.50.
That $3.25 difference may eventually need to support far more than $3.25 of retail price once wholesale economics are considered.
At scale, it also becomes a meaningful cash commitment.
This doesn't mean always choosing inexpensive stock packaging.
Prestige packaging can materially influence perceived value.
It means understanding exactly what you are buying with the additional cost.
Cosmeta's guides to Cosmetic Packaging Compatibility Testing and Airless Pump vs. Dropper vs. Jar explore the technical side of this decision. Pricing adds the commercial side.
The Outer Carton Has to Earn Its Place Too
Secondary packaging is another cost that can become automatic.
Does the product need a carton?
Sometimes yes.
A carton may:
Protect the primary package
Provide regulatory copy space
Support retail merchandising
Improve tamper evidence
Protect a light-sensitive formula
Create the intended prestige presentation
Other times, it primarily creates additional material and COGS.
This is a perfect Clean Beauty 2.0 question.
Don't remove packaging merely so the brand can say it used less packaging.
Don't add packaging because luxury skincare is “supposed” to have a box.
Understand the function first.
Your Retail Price Should Make Sense Beside the Products You Expect Consumers to Compare It With
Cost establishes what a product needs to sell for.
The market helps determine whether consumers will accept that number.
A founder should understand the competitive set:
What type of product is this?
What brands will the consumer compare it with?
What sizes do they offer?
What benefits do they claim?
What evidence do they provide?
What are their prices?
Where are they sold?
What does their packaging communicate?
A $95 moisturizer does not simply compete with every moisturizer.
It competes with the products the target consumer considers reasonable alternatives.
Current beauty-market analysis continues to show meaningful demand across both value and prestige positioning, rather than one price tier winning universally.
The goal is not to copy the competitor's price.
It is to understand the consumer's frame of reference.
Pricing Too Low Can Create Its Own Problem
Founders often worry about being too expensive.
They should.
But a product can also be priced too low.
A low price may:
Leave insufficient margin
Make wholesale impossible
Limit marketing investment
Make future price increases difficult
Conflict with premium positioning
Change how consumers perceive the product
Imagine a prestige biotech serum in custom glass packaging, supported by strong product testing, sitting at $18.
The price may actually undermine the story the brand is trying to tell.
Price communicates something.
It is not merely the result of a spreadsheet.
Pricing Too High Does Not Create Prestige
The opposite is equally important.
Putting a $120 price on a serum does not make it luxury.
The product still has to support that positioning through some combination of:
Performance
Sensory experience
Packaging
Brand equity
Ingredient strategy
Substantiation
Service
Distribution
Consumer trust
Prestige pricing without prestige value is difficult to sustain.
A high retail price creates room for margin.
It also creates a higher consumer expectation.
Founder Ego Should Not Set the Price
This is one of those commercial decisions where objectivity helps.
A founder may feel the product is worth $100 because it took a year to develop.
The consumer does not know how difficult development was.
A founder may want the product at $29 because they personally dislike expensive skincare.
The intended consumer may be perfectly comfortable at $58.
The correct price belongs to the product, consumer, channel, and business model, not the founder's personal shopping habits.
What Gross Margin Should a Skincare Product Target?
There isn't one universal number.
Business model matters enormously.
Public beauty companies often report high gross margins, and a 2026 analysis of several publicly traded beauty businesses put its median around 69%, although those mature companies are not direct templates for an early-stage indie brand.
For a founder, I would not begin with:
“Beauty brands should have X% margin.”
I would begin with:
What margin do we need at each channel after realistic product costs?
Then stress-test the model.
What happens at:
Full-price DTC?
20% DTC promotion?
Wholesale?
Marketplace?
Distributor?
Increased COGS?
Higher freight?
If the product only looks attractive in the best scenario, the economics are fragile.
A Simple Skincare Pricing Example
Imagine a moisturizer intended to retail for $48.
Finished COGS: $6
At full-price DTC:
Revenue = $48
Gross profit = $42
Gross margin = 87.5%
That looks exceptional.
Now assume wholesale revenue is approximately half of MSRP:
Wholesale revenue = $24
Gross profit = $18
Gross margin on the brand's wholesale revenue = 75%
Still attractive.
Now compare another version of the product with $12 COGS.
At $48 DTC:
Gross margin = 75%
At $24 wholesale:
Gross margin = 50%
The second product may still work.
But the business now has far less room for freight increases, promotional support, retailer terms, distribution, or other costs.
This is why the relationship between COGS and intended MSRP matters before the formula is finalized.
Don't Reverse-Engineer the Formula Solely to Hit a Margin Number
There is another side to this.
Suppose the target model says the product should cost $5.
The prototype everyone loves costs $5.75.
That doesn't automatically mean we need to cut $0.75.
Maybe the economics still work.
Maybe a packaging change is easier.
Maybe manufacturing scale will absorb part of the difference.
Maybe the superior sensory profile is worth the cost.
Maybe the formula needs to stay exactly where it is.
A target COGS is a development tool.
It is not a substitute for judgment.
Owning the Quantitative Formula Gives a Brand More Control Over Future COGS
This is where 100% formula ownership becomes particularly relevant to pricing.
If a brand owns its finished quantitative formula, it knows:
Which ingredients are being used
At what percentages
Which raw materials are driving cost
Where expensive technologies sit in the formula
Which ingredients may have technically acceptable alternatives
What can potentially be modified without rebuilding the product from the beginning
That creates options.
If raw-material prices increase, the brand can evaluate alternatives.
If a supplier discontinues an ingredient, the formula can be adapted.
If the brand moves to a different qualified contract manufacturer, it has the quantitative formula needed to begin that transfer.
If the product's COGS becomes too high for a new retail opportunity, the formulation can be intentionally cost-optimized rather than blindly reverse engineered.
This does not mean formulas should constantly be reformulated to save pennies.
It means the brand controls the asset that determines much of the product's economics.
Formula ownership does not provide ownership over a supplier's patented raw material, trademark, proprietary technology, or manufacturing process.
It provides control over the finished quantitative formula and therefore more control over the product's future.
Private Label Has a Different Pricing Advantage
Private label can make excellent commercial sense for some brands.
Development costs are typically lower.
Launch may be faster.
The manufacturer has already solved many of the formulation and production problems.
That can make early unit economics attractive.
The trade-off is control.
The brand may have limited ability to change:
Ingredient percentages
Raw materials
Sensory characteristics
Formula architecture
Manufacturer
That doesn't make private label bad.
It makes it a different business model.
A founder should decide whether speed and lower development complexity or long-term formula control are more important for that product.
Custom Formulation Can Be More Expensive to Develop and More Valuable to Own
Custom formulation adds development cost before the first commercial unit is sold.
That needs to be recognized in the business plan.
But development expense and unit COGS are different things.
A custom formula can create value through:
Product differentiation
Specific sensory design
Ingredient strategy
Retailer or certification alignment
Claims architecture
Manufacturing flexibility
Formula ownership
Long-term product evolution
The question shouldn't simply be:
“Which option costs less to launch?”
It should be:
“What kind of product asset are we trying to build?”
For some products, private label is completely rational.
For products intended to become distinctive long-term brand assets, custom development may justify the additional upfront investment.
Development Cost Should Not Be Loaded Into the First Production Run
Another mistake is trying to recover every startup expense from the first batch.
Suppose formulation and product development cost $15,000.
That does not necessarily mean you should divide $15,000 by your first 1,000 units and add $15 to COGS.
Development is generally an upfront investment or amortizable business expense rather than the recurring manufacturing cost of every future unit.
The distinction matters when evaluating long-term unit economics.
Likewise, photography, trademark work, website development, launch PR, and brand identity are real costs.
They matter to the business.
They are not necessarily part of recurring product COGS.
Cash Flow Can Matter More Than Margin at Launch
A product can have excellent margins and still create a cash problem.
Imagine ordering:
10,000 units × $8 landed cost = $80,000
The gross-margin spreadsheet may look fantastic.
The brand still needs $80,000 to purchase the inventory.
Then it needs cash for marketing, freight, warehouse costs, employees, and the next production run before every unit from the first run has necessarily been sold.
This is why MOQ, payment terms, deposits, lead time, inventory turns, and reorder planning matter alongside gross margin.
A profitable product can still starve a business of cash.
Pricing Is Also a Product Portfolio Decision
Not every SKU needs to perform the same strategic role.
A brand might have:
Entry product: lower price, easier first purchase.
Hero treatment: stronger margin or premium positioning.
Routine products: designed for frequent replenishment.
Bundles: increase average order value.
Professional or specialty product: supports another channel.
This allows pricing to work across the brand instead of forcing every product into the same margin and price architecture.
The important thing is that each SKU has a reason to exist financially as well as cosmetically.
Sometimes the Best Pricing Decision Happens Before the Formula Exists
This is ultimately why I think pricing belongs in product development.
Before formulation begins, a founder should ideally know approximately:
Target consumer
Product category
Likely MSRP
Expected sales channels
Approximate packaging tier
Target COGS
Intended fill size
Positioning
Certification or retailer goals
That does not limit innovation.
It gives innovation a commercial target.
A chemist can make a $20 moisturizer.
A $60 moisturizer.
A $150 moisturizer.
The interesting question is not which one can be made.
It is which one the brand actually needs.
Key Takeaways
Pricing a skincare product starts with understanding the complete unit economics, not choosing a retail markup after development is finished.
COGS should include the direct costs required to produce the finished product, while gross margin tells the brand how much revenue remains after those costs. Gross margin is not the same as net profit.
DTC, wholesale, retail, Amazon, and distribution can create very different economics for the same MSRP.
Discounts, customer acquisition, fulfillment, commissions, shipping, returns, and promotions can materially reduce what looks like an excellent gross margin.
Formula cost matters, but packaging, manufacturing volume, fill size, and component choices can matter just as much.
Most importantly, the formula should be developed against a commercial target. The goal isn't to create the cheapest product possible. It is to create the strongest product the intended business model can support.
Cosmeta's Perspective
Pricing is one of the reasons I don't think formulation should happen in a vacuum.
A cosmetic chemist can keep adding things.
More actives.
More expensive technology.
More complex delivery systems.
More luxurious emollients.
At some point, the formula may become technically beautiful and commercially impossible.
The opposite is just as dangerous.
If cost becomes the only objective, you can engineer everything distinctive out of the product.
The real skill is finding the point where performance, sensory, claims, differentiation, manufacturing, COGS, and retail price all make sense together.
That is what commercial formulation means to me.
And it is one of the reasons owning the quantitative formula can become so valuable over time. The product can evolve as the company evolves. COGS can be revisited. Suppliers can change. Manufacturing can move. New technologies can be incorporated without surrendering control of the product itself.
A great formula is chemistry.
A commercially successful formula also has to understand math.
Ready for the Next Step
Before developing the next skincare product, define the price architecture along with the product brief. Know who will buy it, where you want to sell it, approximately what it should retail for, and what the finished unit needs to cost. That gives formulation, packaging, and manufacturing a real commercial target instead of asking the numbers to work after every important decision has already been made.
FAQs
-
There is no universal margin because DTC, wholesale, marketplaces, and distributor models have different economics. Beauty businesses often operate with relatively high gross margins compared with many consumer categories, but gross margin alone doesn't determine profitability. Customer acquisition, fulfillment, returns, promotions, overhead, and channel costs must also be considered. Current public-company beauty data continue to show gross margins around the high-60% range for several established businesses, but an early-stage brand should build its model from its own costs and channels rather than copy a benchmark.
-
There isn't one required ratio. Beauty founders often hear rules such as keeping COGS around 10% to 25% of retail or pricing near 8X to 10X COGS, largely because the MSRP may eventually need to support wholesale economics. Those are useful screening tools, not universal rules. The appropriate relationship depends on channel, packaging, positioning, scale, and the rest of the business model.
-
Use:
Gross Margin % = (Selling Price − COGS) ÷ Selling Price × 100
If a product sells directly to the consumer for $50 and has $10 COGS, its gross margin is 80%. If the brand sells that same product wholesale for $25, its gross margin at wholesale becomes 60%. Always calculate margin using the actual revenue the brand receives in that channel, not simply the consumer's MSRP.
-
You should at least establish a realistic target retail range and target COGS before formulation gets too far along. That gives the formulator useful boundaries for ingredient selection, active levels, packaging, fill size, and manufacturing strategy. The exact price can evolve, but waiting until development is finished can leave the brand with a product whose economics no longer fit its intended channel.
-
Custom formulation generally requires more upfront development investment because the product is being developed specifically for the brand. Private label can offer lower development costs and faster commercialization because the underlying formula already exists. Custom development can provide greater control over formula architecture, ingredient percentages, differentiation, manufacturing options, and formula ownership, so the better choice depends on the brand's goals rather than development cost alone.
